纳米氧化锌作为抗肿瘤药物载体的研究进展  

Research Progress of Nano-zinc Oxide as an Anti-tumor Drug Carrier

作　　者：李树欣 赵莹莹[1] 李鑫[1] Li Shuxin;Zhao Yingying;Li Xin(Pharmaceutical Engineering,School of Pharmacy,University of Commerce,Harbin 150076,China)

机构地区：[1]哈尔滨商业大学药学院制药工程专业,黑龙江哈尔滨150076

出　　处：《广东化工》2020年第17期78-79,72,共3页Guangdong Chemical Industry

摘　　要：纳米氧化锌作为新型无机纳米载体,价格便宜、生物相容性高,其固有的抗肿瘤和抗菌活性常常使其优于其他常用药物载体。美国食品药品监督管理局(FDA)已将氧化锌列入安全物质之一,本文概述了纳米氧化锌的常见制备方法及抗肿瘤作用机制。Nano-zinc oxide,as a new inorganic nano-carrier,is cheap and has high biocompatibility,and its inherent anti-tumor and anti-bacterial activity often makes it superior to other commonly used drug carriers.The US Food and Drug Administration(FDA)has listed zinc oxide as one of the safe substances.This article outlines the common preparation methods and antitumor mechanism of zinc oxide nanoparticles.

关 键 词：纳米氧化锌 制备方法 抗肿瘤作用机制 

分 类 号：TQ[化学工程]